NCT05744713Enrolling By Invitation不适用
An Observational Study of Patients With Chronic Liver Disease
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 500,000
- 试验地点
- 18
- 主要终点
- To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease
研究概览
简要总结
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Disease Cohort
- •Adult* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface
- •Engaged Cohort
- •Adult* patients diagnosed and managed for CLD/cirrhosis invited to participate
- •Ability to provide written informed consent
排除标准
- •Disease Cohort
- •Manual removal (sponsor or site request)
- •No EHR interface encounter > 3 years.
- •Engaged Cohort
- •Patient expressed desire to withdraw consent to complete PROs
- •Failure to complete PROs within 24 weeks of initial invitation
- •Greater than 24 months lapse of survey completion after baseline surveys completed
- •Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.
研究组 & 干预措施
Disease Cohort
干预措施: Observational (Other)
Engaged Cohort
干预措施: Observational (Other)
结局指标
主要结局
To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease
时间窗: 20 Years
To establish learning health networks focused on quality of care for patients
时间窗: 20 Years
To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis
时间窗: 20 Years
次要结局
- To evaluate longitudinal and patient reported outcomes in CLD/Cirrhosis(20 Years)
- To evaluate provider management practices in the treatment of patients with CLD/Cirrhosis(20 Years)
研究者
研究点 (18)
Loading locations...
相似试验
尚未招募
不适用
An Observational Study of Patients With Metabolic Syndrome and Related ConditionsMetabolic SyndromeNCT05842811Target PharmaSolutions, Inc.2,000,000
招募中
不适用
Evaluation of Patients With Liver DiseaseHepatitis DHepatitis BLiver DiseaseHepatitis CNCT00001971National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8,050
进行中（未招募）
不适用
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in ItalyRelapse LeukemiaRefractory LeukemiaChronic Lymphocytic LeukemiaNCT04282811Gruppo Italiano Malattie EMatologiche dell'Adulto321
撤回
不适用
An Observational Study of Patients With Chronic Kidney DiseaseKidney Disease, ChronicEnd Stage Kidney DiseaseNCT05774392Target PharmaSolutions, Inc.500,000
招募中
不适用
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesNAFLD - Nonalcoholic Fatty Liver DiseaseMetabolic SyndromeNASH - Nonalcoholic SteatohepatitisHCC - Hepatocellular CarcinomaDiabetesFatty LiverCirrhosisLiver CancerObesityNCT04371042Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,000